Notably, despite the growing number of immunotherapies targeting p53, these approaches are still in the early stages of development
Viability scores of 3 = motile, no changes to morphology and transparency, 2 = reduced motility and/or some damage to tegument as well as reduced transparency and increased granularity, 1 = severe reduction of motility and/or damage to tegument with high opacity and high granularity, and 0 = dead
The biggest impact is when tumors are in very atypical locations, which happens less than 5% of the time
Lightweight, fast-absorbing formula
doi: 10.1210/jc.2005-1696 26 LiYChenCMaYXiaoJLuoGLiYet al
Patricks Day and in Las Vegas during March Madness